Skip to content
10-Q

Quarterly Report

Durata Therapeutics, Inc.

0001193125-13-428880

← back to feed
Filed
Nov 6, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Oct 31, 2013 26.63M sh
Capex Q3 2013 · Sep 30, 2013 $1.16M
Capex Q3 2013 · Sep 30, 2012 $507.6K
Long Term Debt Q3 2013 · Sep 30, 2013 $15.87M
Short Term Debt Q3 2013 · Sep 30, 2013 $2.84M
Stockholders Equity Q3 2013 · Sep 30, 2013 $53.42M
Stockholders Equity Q3 2013 · Dec 31, 2012 $43.87M
Current Liabilities Q3 2013 · Sep 30, 2013 $11.84M
Current Liabilities Q3 2013 · Dec 31, 2012 $21.5M
Total Liabilities Q3 2013 · Sep 30, 2013 $51.42M
Total Liabilities Q3 2013 · Dec 31, 2012 $42.68M
Current Assets Q3 2013 · Sep 30, 2013 $69.63M
Current Assets Q3 2013 · Dec 31, 2012 $51.2M
Total Assets Q3 2013 · Sep 30, 2013 $104.84M
Total Assets Q3 2013 · Dec 31, 2012 $86.55M
Rd Expense Q3 2013 · Sep 30, 2013 $117.04M
Rd Expense Q3 2013 · Sep 30, 2012 $18.96M
Rd Expense Q3 2013 · Sep 30, 2012 $42.25M
Net Income Q3 2013 · Sep 30, 2013 −$153.8M
Net Income Q3 2013 · Sep 30, 2012 −$21.77M
Net Income Q3 2013 · Sep 30, 2012 −$49.22M
Operating Income Q3 2013 · Sep 30, 2013 −$157.6M
Operating Income Q3 2013 · Sep 30, 2012 −$21.79M
Operating Income Q3 2013 · Sep 30, 2012 −$49.24M
Stock Issued Q3 2013 · Apr 17, 2013 8.22M sh
Cash And Equivalents Q3 2013 · Sep 30, 2012 $60.79M
Cash And Equivalents Q3 2013 · Dec 31, 2011 $11.49M